SEC Form 4 · accession 0001628068-16-000002
GENOCEA BIOSCIENCES, INC. · GNCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric S Hoffman
Officer — Chief Business Officer
Period of report
Nov 7, 2016
Accepted (ET)
Nov 9, 2016 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001457612
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 7, 2016 | P | 4,000 | $3.41 | A | 8,790 | D | |
| Common Stock | Nov 8, 2016 | P | 3,000 | $3.59 | A | 11,790 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Amount adjusted to reflect shares acquired under the registrant's Employee Stock Purchase Plan.